Home / 2591.HK : HKSE

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does 2591.HK make money? Does 2591.HK have pricing power? What's the Earnings Whisper? Will 2591.HK profit more as the business scales? What is 2591.HK's management track record? Is 2591.HK's current price justified?

Guangzhou Innogen Pharmaceutl Grp Co Ltd

HKD 4 -$26.42 (-86.85%)

HKSE · 15 Sep 2026 03:24 UTC

Previous Close

HKD 4.04

Day Range

HKD 3.91HKD 4.09

Year Range

HKD 3.44HKD 48.36

Market Cap

1.83B

AVG Volume

6.27M

Trailing/Forward PE

-4.63/-

PEG ratio

0.05

Dividend Yield

Next Earnings Date

Primary Exchange

Hong Kong Stock Exchange

Revenue (CNY)

2591.HK Revenue (CNY) by quarter
Period	Revenue (CNY)
26 Q2	77.14M
25 Q4	73.81M
25 Q2	55.31M
24 Q4	0
24 Q2	0
23 Q4	0
23 Q2	0

Net Income (CNY)

2591.HK Net Income (CNY) by quarter
Period	Net Income (CNY)
26 Q2	-113.87M
25 Q4	-215.24M
25 Q2	-120M
24 Q4	-101.29M
24 Q2	-75.88M
23 Q4	-381.93M
23 Q2	-358.39M

Operating Income (CNY)

2591.HK Operating Income (CNY) by quarter
Period	Operating Income (CNY)
26 Q2	-116.4M
25 Q4	-214.94M
25 Q2	-113.63M
24 Q4	-90.13M
24 Q2	-82.66M
23 Q4	-388.88M
23 Q2	-366.08M

EBITDA (CNY)

2591.HK EBITDA (CNY) by quarter
Period	EBITDA (CNY)
26 Q2	-109.26M
25 Q4	-209.3M
25 Q2	-115.55M
24 Q4	-93.8M
24 Q2	-72.97M
23 Q4	-379.26M
23 Q2	-355.84M

Cash Flows (CNY)

2591.HK Cash Flows (CNY) by quarter
Period	Cash Flows (CNY)
26 Q2	-138.59M
25 Q4	-223.51M
25 Q2	-89.59M
24 Q4	-85.12M
24 Q2	-84.66M
23 Q4	-100.61M
23 Q2	-75.98M

EPS (CNY)

2591.HK EPS (CNY) by quarter
Period	EPS (CNY)
26 Q2	-0.25
25 Q4	-0.49
25 Q2	-0.28
24 Q4	-0.23
24 Q2	-0.17
23 Q4	-0.83
23 Q2	-0.79

Expenses (CNY)

2591.HK Expenses (CNY) by quarter
Period	Expenses (CNY)
26 Q2	168.25M
25 Q4	296.02M
25 Q2	165.63M
24 Q4	83.58M
24 Q2	76.06M
23 Q4	386.28M
23 Q2	360.7M

Cash & Debt (CNY)

2591.HK Cash & Debt (CNY) by quarter
Period	Cash & Debt (CNY)
26 Q2	1.02B
25 Q4	1.21B
25 Q2	732.5M
24 Q4	796.88M
24 Q2	866.17M
23 Q4	942.54M

Debt ratios

2591.HK Debt ratios by quarter
Period	Debt ratios
24 Q4	0.87

Margins

2591.HK Margins by quarter
Period	Margins
26 Q2	63.89%
25 Q4	88.68%
25 Q2	89.45%

Return on Capital

2591.HK Return on Capital by quarter
Period	Return on Capital
26 Q2	-12.09%
25 Q4	-20.42%
24 Q4	-12.72%
24 Q2	-8.58%
23 Q4	-54.33%

Shares Outstanding

2591.HK Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	456.82M
25 Q4	442.21M
25 Q2	420.26M
24 Q4	456.82M
24 Q2	456.82M
23 Q4	456.82M
23 Q2	456.82M

Book Value Per Share (CNY)

2591.HK Book Value Per Share (CNY) by quarter
Period	Book Value Per Share (CNY)
26 Q2	2.06
25 Q4	2.38
24 Q4	1.74
24 Q2	1.94
23 Q4	1.54

Total Assets (CNY)

2591.HK Total Assets (CNY) by quarter
Period	Total Assets (CNY)
26 Q2	1.3B
25 Q4	1.57B
25 Q2	907.69M
24 Q4	934.8M
24 Q2	980.5M
23 Q4	1.1B

Free Cash Flow Yield

2591.HK Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Aug 25	-1.56%
Aug 25	-1.44%

Price to Book

2591.HK Price to Book by quarter
Period	Price to Book
Sep 26	1.45
Sep 26	1.43
Sep 26	1.29
Aug 26	1.37
Aug 26	1.47
Aug 26	2.38
Aug 26	2.74
Jul 26	2.62
Jul 26	2.75
Jul 26	2.73
Jul 26	2.9
Jul 26	2.93
Jun 26	2.48
Jun 26	2.73
Jun 26	3.04
Jun 26	3.62
May 26	4.03
May 26	4.42
May 26	4.51
May 26	4.61
Apr 26	5.12
Apr 26	6.17
Apr 26	7.35
Apr 26	7.83
Apr 26	7.69
Aug 25	27.87
Aug 25	30.14

No video analysis for this stock yet. Request one from our team.

AI Analysis

Guangzhou Innogen Pharmaceutl Grp Co Ltd

Video analysis: 2591.HK

Similar companies